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                EFFECTS OF NICOTINE ON RABBIT BONE MARROW DERIVED OSTEOBLASTIC CELLS  
*Sylvester, S; *Norman, TL; France, J, MD; +*Mukherjee, N 
*West Virginia University, Morgantown, WV  
Introduction:  
Spinal fusion is commonly performed to correct spinal instability in 
patients. The rate of nonunion after spinal fusion has been reported to be up 
to 3-4 times higher in patients who use tobacco products. Nicotine, the 
major constituent of cigarettes, is thought to cause this increased non-union. 
Nicotine levels in tobacco users are 10-70ng/ml in the blood (1) and as high 
as 1.56 mg/ml in the saliva of smokeless tobacco users (2). 
In previous in vivo studies conducted in our laboratory (3) posterolateral 
spinal fusion with autologous bone graft was performed in New Zealand 
white rabbits that were administered with nicotine via patches. The serum 
concentration of nicotine was maintained at 78 49ng/ml. Fusion was 
assessed via blinded manual palpation by two surgeons and a radiographic 
score according to Boden et al., 1995 (4). The nicotine group showed 
significantly increased fusion rates (66.0 vs. 37.5, p<0.05) over controls and 
a higher radiographic score (1.91 vs. 1.56). The overall goal of this research 
is to investigate why nicotine significantly increased the level of fusion in 
vivo. Previously, we had optimized a system in which we isolated cells from 
bone marrow of New Zealand white rabbits and cultured them in media that 
encouraged these cells to proceed down the osteoblastic phenotype (5). In 
this study, we exposed these cells to various levels of nicotine and evaluated 
the ability of these cells to express various markers of osteoblastic activity.   
Methods:  
Bone marrow was isolated from adult male New Zealand white rabbit 
femurs. They were expanded in monolayer culture adapted from standard 
protocols developed for rat models (5) (6) (7).  Approximately 3x103 cells 
were placed in each treatment well of a 24 well plate and culture medium 
containing Minimum essential medium (MEM) and 40ng/mL 
Dexamethasone were changed every three days.  All treatments were given 
2.8x10-4M concentration of L-ascorbic acid and 10mM concentration of -
glycerophosphate after day 7 and with every media change after that (8) (9).  
Cells were then exposed to one of six concentration of nicotine:  20, 40, 
80ng/ml and 10, 100, 250µg/ml. Control cells were not exposed to nicotine.  
The media was changed every three days.  Wells were stained with alkaline 
phosphatase staining kit (Sigma, St. Louis, MO) to determine the activity of 
the alkaline phosphatase enzyme, an early indicator of osteogenesis (10) and 
von Kossa staining (11), which indicates mineralization, a late stage of 
osteogenesis                 
Fig 1: Rabbit bone marrow derived cells were cultured in monolayer under 
different conditions and tested for alkaline phosphatase activity at different 
time points. Alkaline Phosphatase enzyme activity was significantly 
enhanced by nicotine at 100µg/ml dose over the control at p<0.05.  
  
Essential Results:   
Control cells behaved as expected, with increasing alkaline phosphatase 
activity up to three weeks and dropping off slightly at 4 weeks. As expected, 
there was no appreciable von Kossa staining up to three weeks, but after 4 
weeks, the control cells stained positively for von Kossa.  A two-way 
ANOVA using dose and time as variables showed that the 100ug/ml dose of 
nicotine significantly enhanced (p<0.05) alkaline phosphatase activity over 
control (Figure 1). Von Kossa staining was not observed at week 1 – 3 
sampling time points.  Week 4 showed a positive stain for Von Kossa 
(Figure 2).  A one-way ANOVA using dose as the variable was performed 
and the 100µg/ml and 250µg/ml dose had significantly greater (p<0.05) 
mineralization than control.              
Fig 2:  Rabbit bone marrow derived cells were cultured in monolayer and 
tested for Calcium deposition by Von Kossa staining at different time points.  
Von Kossa staining was not observed through day 21 but appeared at day 
28.  100µg/ml and 250µg/ml treatments showed significantly higher 
mineralization than control on day 28 [p<0.05]  
Discussion:  
This work demonstrated that bone marrow derived osteoblastic 
cells increase alkaline phosphatase activity in the presence of nicotine, 
although statistically significant effects are seen for high doses in the 
microgram range. Maximum effect was observed at 100ug/ml dosage. 
Mineralization is enhanced when nicotine is administered with higher 
dosages resulting in more mineralization. In a similar study nicotine has 
been shown to have a significant dose-dependent effect on the activity of 
osteoblastic cell lines with increased alkaline phosphatase activity and 
deposition of calcium (12). Thus, increased fusion rates we observed in 
nicotine rabbits in vivo might be explained by enhanced osteoblastic activity 
due to nicotine. 
Interestingly, in other models of posterior spinal fusion, nicotine 
has been shown to decrease fusion rates. Decreased angiogenesis measured 
by decreased vascular ingrowths into autogenous cancellous bone grafts (13) 
and inhibition of expression of cytokines associated with neovascularization. 
(14) have been observed in these models. However in many other models 
such as in tumors, or ischemia models, nicotine is a potent enhancer of 
angiogenesis (15). Therefore further investigation needs to be performed to 
fully understand the relationship between nicotine and angiogenesis in bone 
repair. The overall relationship between fusion rates and nicotine may 
depend on many factors, which include both angiogenesis and osteoblastic 
activity.  
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